RankAlpha logo
Back to Rankings

HIND

VyomeD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
HIND vs peer average
46/100
HIND vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KTTA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $15.97M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKTTAPasithea Therapeutics
HIND
Vyome
KTTA
Pasithea Therapeutics
Grade
D
D
Momentum
33
83
Value
54
57
Sentiment
-
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs KTTA

HIND / KTTA
Grade Position
In line
HIND vs. peer average (D vs. D)
46/100
Momentum
33
KTTA
Value
54
KTTA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HIND
1
KTTA
Pasithea Therapeutics Corp Common
D
40/100
Even
2
NRSN
Neurosense Therapeutics Ltd Common
F
20/100
+1
3
MDCX
Medicus Pharma Ltd Common
A
100/100
-3
4
CTXR
Citius Pharmaceuticals Inc Common
F
20/100
+1
5
LPCN
Lipocine Inc Common
B
80/100
-2
KTTA is the first peer returned for this comparison set.